Arrowhead Pharmaceuticals, Inc. (ARWR)
47.15
-2.21
(-4.48%)
USD |
NASDAQ |
Nov 12, 16:00
47.26
+0.11
(+0.23%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Price to Book Value : 14.29 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 14.29 |
| November 11, 2026 | 14.96 |
| November 10, 2026 | 14.86 |
| November 09, 2026 | 14.93 |
| November 06, 2026 | 17.63 |
| November 05, 2026 | 17.42 |
| November 04, 2026 | 18.69 |
| November 03, 2026 | 18.05 |
| November 02, 2026 | 18.06 |
| October 30, 2026 | 18.16 |
| October 29, 2026 | 18.34 |
| October 28, 2026 | 18.25 |
| October 27, 2026 | 17.90 |
| October 26, 2026 | 17.88 |
| October 23, 2026 | 17.59 |
| October 22, 2026 | 17.69 |
| October 21, 2026 | 17.84 |
| October 20, 2026 | 17.86 |
| October 19, 2026 | 17.35 |
| October 16, 2026 | 16.95 |
| October 15, 2026 | 17.74 |
| October 14, 2026 | 17.70 |
| October 13, 2026 | 17.62 |
| October 12, 2026 | 18.41 |
| October 09, 2026 | 19.02 |
| Date | Value |
|---|---|
| October 08, 2026 | 18.41 |
| October 07, 2026 | 18.64 |
| October 06, 2026 | 18.66 |
| October 05, 2026 | 18.90 |
| October 02, 2026 | 19.46 |
| October 01, 2026 | 19.64 |
| September 30, 2026 | 19.84 |
| September 29, 2026 | 20.09 |
| September 28, 2026 | 19.85 |
| September 25, 2026 | 19.98 |
| September 24, 2026 | 20.03 |
| September 23, 2026 | 20.30 |
| September 22, 2026 | 21.79 |
| September 21, 2026 | 20.86 |
| September 18, 2026 | 20.15 |
| September 17, 2026 | 20.54 |
| September 16, 2026 | 19.95 |
| September 15, 2026 | 21.43 |
| September 14, 2026 | 24.46 |
| September 11, 2026 | 25.12 |
| September 10, 2026 | 25.09 |
| September 09, 2026 | 25.05 |
| September 08, 2026 | 25.80 |
| September 04, 2026 | 26.18 |
| September 03, 2026 | 26.22 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 13.67 |
| Sarepta Therapeutics, Inc. | 1.123 |
| Twist Bioscience Corp. | 16.06 |
| Revolution Medicines, Inc. | 15.88 |
| Immunome, Inc. | 4.678 |
Price to Book Value Related Metrics
| PS Ratio | 9.898 |
| PEG Ratio | -0.2711 |
| Price | 47.15 |
| Earnings Yield | -4.76% |
| Market Cap | 6.655B |
| PEGY Ratio | -0.2711 |